Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1REGN88----[1] 46 💬
2SAR153191 (REGN88)[1] Sarilumab (REGN88)[1] Sarilumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
3Sarilumab SAR153191 (REGN88)[1] Sarilumab (REGN88)[1] Sarilumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
4SarilumabProduct Code: SAR153191 (REGN88)Pharmaceutical Form: Solution for injectionINN or Proposed INN: SARILUMABCurrent Sponsor code: SAR153191Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 175-----[1] 107 💬